Novartis

News

Novartis and FDA hail 'historic' Kymriah, first ever approve...

In the end, the FDA took little more than six weeks to give final approval to Kymriah, the first ever CAR-T treatment.

Events

Partner Content

Tumour Models London 2017

Enhance Translational Decision Making

Events

Partner Content

CRISPR & Precision Gene Editing Congress - Berlin 2017

CRISPR & Precision Gene Editing Congress Berlin 2017

News

Show ambition with UK life sciences plan, Novartis tells gov...

Drugmaker concerned over access to new drugs

Views & Analysis

Novartis' Basel HQ: the company is looking for more blockbusters to lift revenues

Novartis move shows chief digital officers can be prime chan...

GSK and Novartis have just hired execs from the world of retail to be their chief digital officers - with the hope that they can lead transformation in R&D, and relationships with customers

News

NICE approval would let Novartis' Kisqali steal a march on I...

Novartis' breast cancer treatment Kisqali has gained final EU approval today - and the company is confident it can follow this with a swift reimbursement recommendation from the UK's NICE.<

Novartis and FDA hail 'historic' Kymriah, first ever approve...

Tumour Models London 2017

CRISPR & Precision Gene Editing Congress - Berlin 2017

Show ambition with UK life sciences plan, Novartis tells gov...

Novartis move shows chief digital officers can be prime chan...

NICE approval would let Novartis' Kisqali steal a march on I...

FDA kicks off review of Takeda's narcolepsy hopeful

How to meet your physicians where they are online

Novartis

Editor's Picks